Neuroendocrine tumors (NETs) constitute a health threat to children and young adults. The incidence and prevalence of NETs in this age group is comparable to that of neuroblastoma, yet there is very little research on neuroendocrine malignancies, and no effective treatment for children with metastatic disease, over half of whom die within five years of diagnosis.
At 15 months old, August was diagnosed with bilateral retinoblastoma. By the time her family found out, she was basically blind. ALSF's Travel For Care program helped August get to the treatments she needed, and today she is 3 years old and can see!
